Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCollagen Matrix

About this trial

Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.

Eligibility criteria

Qualifiers

The general population will be included in the study where a dura substitute is required for the repair of dura mater.

Disqualifiers

Patients that have conditions which are contraindicated per the instructions for use (IFU) would be excluded.

Trial design

Treatments tested in this trial

  • Post Market Study

Treatment groups

No treatment groups listed

Sponsors and collaborators